GlassScriptPhysician profile
Laura Porter Guyer
NPI 1780771816
$994.34
in general payments reported to CMS, 2019-2025
17 companies · $56.42 in 2025
The $56.42 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.10 · 2022: $334 · 2023: $295 · 2024: $252 · 2025: $56.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $289.29 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $118.79 | 2022-2023 | |
| Abbvie INC. | $79.00 | 2022 | |
| Lilly USA, LLC | $75.73 | 2022-2024 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $73.96 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $51.14 | 2021-2023 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.21 | 2022-2024 | Jardiance |
| Exact Sciences Corporation | $41.56 | 2023-2024 | Cologuard Collection Kit |
| Insulet Corporation | $34.06 | 2022-2023 | Omnipod |
| Sanofi-Aventis U.S. LLC | $30.87 | 2022-2023 | |
| Pfizer INC. | $29.74 | 2022-2023 | |
| Glaxosmithkline, LLC. | $25.46 | 2024 | Trelegy Ellipta |
| Ascensia Diabetes Care US INC. | $23.94 | 2023 | |
| Sumitomo Pharma America, INC. | $21.28 | 2023 | Gemtesa |
| Alnylam Pharmaceuticals INC. | $18.95 | 2024 | Givlaari |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zealand Pharma US, INC. | $18.78 | 2022 | |
| Merck Sharp & Dohme LLC | $15.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Porter Guyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.